 Infection Surveillance Solutions Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Infection Surveillance Solutions Market is witnessing notable growth as healthcare systems across the world place increasing importance on infection prevention, patient safety, and effic... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global Infection Surveillance Solutions Market is witnessing notable growth as healthcare systems across the world place increasing importance on infection prevention, patient safety, and efficient clinical management. Infection surveillance solutions play a crucial role in identifying, tracking, and managing infections within healthcare settings, helping institutions reduce risks associated with healthcare-associated infections. As hospitals and healthcare providers continue to adopt digital technologies, these solutions are becoming essential tools for maintaining high standards of care and regulatory compliance.Market Insights The Infection Surveillance Solutions Market is projected to reach a valuation of USD 721.22 million in 2026 and is expected to grow to USD 1,414.4 million by 2033, registering a CAGR of 10.10% during the forecast period. This growth reflects the increasing demand for advanced monitoring systems that can provide real-time insights into infection patterns. The market is benefiting from the integration of advanced technologies such as artificial intelligence, cloud computing, and data analytics, which enhance the effectiveness of infection detection and reporting systems. Market Drivers A key factor driving the market is the growing prevalence of healthcare-associated infections, which continue to pose significant challenges to healthcare systems globally. These infections not only increase patient morbidity and mortality but also lead to higher treatment costs and extended hospital stays. As a result, healthcare providers are increasingly investing in infection surveillance solutions to mitigate these risks. Another important driver is the implementation of stringent government regulations and healthcare policies aimed at improving patient safety and reducing infection rates. Regulatory bodies are mandating the adoption of surveillance systems to ensure compliance with infection control standards. Additionally, the growing awareness among healthcare professionals regarding the importance of early detection and prevention of infections is further supporting market growth. Business Opportunity The market presents strong growth opportunities, particularly in emerging economies where healthcare infrastructure is rapidly evolving. The increasing adoption of cloud-based and web-based solutions is enabling healthcare facilities to implement cost-effective and scalable infection surveillance systems. These solutions are especially beneficial for small and medium-sized healthcare providers that may lack extensive IT infrastructure. Technological advancements such as predictive analytics and machine learning are creating new possibilities for proactive infection management. These innovations allow healthcare providers to anticipate potential outbreaks and take preventive measures in advance. Furthermore, partnerships between healthcare organizations and technology providers are driving innovation and expanding market reach. Region Analysis North America holds a dominant position in the Infection Surveillance Solutions Market, supported by its advanced healthcare systems, high adoption of digital technologies, and strong regulatory framework. The region’s focus on patient safety and quality care continues to drive the demand for infection surveillance solutions. Europe also represents a significant market, driven by strict healthcare regulations and increasing investments in healthcare IT infrastructure. Countries in this region are actively adopting advanced surveillance systems to enhance infection control measures. The Asia Pacific region is expected to experience the fastest growth during the forecast period. Rapid urbanization, increasing healthcare spending, and expanding hospital networks are key factors contributing to market growth in this region. Governments are also taking initiatives to improve healthcare quality, which is encouraging the adoption of infection surveillance solutions. Latin America and the Middle East & Africa are gradually emerging as potential markets. Improvements in healthcare infrastructure and rising awareness about infection control are supporting market expansion, although certain challenges such as limited resources may impact growth to some extent. Key Players The Infection Surveillance Solutions Market is characterized by intense competition, with leading companies focusing on innovation and strategic initiatives to strengthen their market presence. Key players include: • Becton, Dickinson and Company • Premier, Inc. • Wolters Kluwer N.V. • Cerner Corporation • Baxter International Inc. • RLDatix • VigiLanz Corporation • GOJO Industries, Inc. • bioMérieux SA • Clinisys • Merative • Ecolab Inc. • Vecna Technologies, Inc. • PointClickCare • Medexter Healthcare These organizations are investing heavily in research and development, forming strategic alliances, and expanding their product portfolios to meet the evolving needs of healthcare providers. Market Segmentation By Product & Services • Software o On-premise Software o Web-based Software • Up to 50 hp o Product Support & Maintenance Services o Implementation Services o Training & Consulting services By End User • Hospitals o Large Hospitals o Medium Sized Hospitals o Small Hospitals • Long-term Care Facilities o Nursing Homes o Skilled Nursing Facilities o Assisted-Living Facilities • Other End Users By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Infection Surveillance Solutions Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Infection Surveillance Solutions Market Outlook, 2020-2033 3.1. Global Infection Surveillance Solutions Market Outlook, by Product & Services, Value (US$ Mn), 2020-2033 3.1.1. Software 3.1.1.1. On-premise Software 3.1.1.2. Web-based Software 3.1.2. Up to 50 hp 3.1.2.1. Product Support & Maintenance Services 3.1.2.2. Implementation Services 3.1.2.3. Training & Consulting services 3.2. Global Infection Surveillance Solutions Market Outlook, by End User, Value (US$ Mn), 2020-2033 3.2.1. Hospitals 3.2.1.1. Large Hospitals 3.2.1.2. Medium Sized Hospitals 3.2.1.3. Small Hospitals 3.2.2. Long-term Care Facilities 3.2.2.1. Nursing Homes 3.2.2.2. Skilled Nursing Facilities 3.2.2.3. Assisted- Living Facilities 3.2.3. Other End Users 3.3. Global Infection Surveillance Solutions Market Outlook, by Region, Value (US$ Mn), 2020-2033 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Latin America 3.3.5. Middle East & Africa 4. North America Infection Surveillance Solutions Market Outlook, 2020-2033 4.1. North America Infection Surveillance Solutions Market Outlook, by Product & Services, Value (US$ Mn), 2020-2033 4.1.1. Software 4.1.1.1. On-premise Software 4.1.1.2. Web-based Software 4.1.2. Up to 50 hp 4.1.2.1. Product Support & Maintenance Services 4.1.2.2. Implementation Services 4.1.2.3. Training & Consulting services 4.2. North America Infection Surveillance Solutions Market Outlook, by End User, Value (US$ Mn), 2020-2033 4.2.1. Hospitals 4.2.1.1. Large Hospitals 4.2.1.2. Medium Sized Hospitals 4.2.1.3. Small Hospitals 4.2.2. Long-term Care Facilities 4.2.2.1. Nursing Homes 4.2.2.2. Skilled Nursing Facilities 4.2.2.3. Assisted- Living Facilities 4.2.3. Other End Users 4.3. North America Infection Surveillance Solutions Market Outlook, by Country, Value (US$ Mn), 2020-2033 4.3.1. U.S. Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 4.3.2. U.S. Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 4.3.3. Canada Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 4.3.4. Canada Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 4.4. BPS Analysis/Market Attractiveness Analysis 5. Europe Infection Surveillance Solutions Market Outlook, 2020-2033 5.1. Europe Infection Surveillance Solutions Market Outlook, by Product & Services, Value (US$ Mn), 2020-2033 5.1.1. Software 5.1.1.1. On-premise Software 5.1.1.2. Web-based Software 5.1.2. Up to 50 hp 5.1.2.1. Product Support & Maintenance Services 5.1.2.2. Implementation Services 5.1.2.3. Training & Consulting services 5.2. Europe Infection Surveillance Solutions Market Outlook, by End User, Value (US$ Mn), 2020-2033 5.2.1. Hospitals 5.2.1.1. Large Hospitals 5.2.1.2. Medium Sized Hospitals 5.2.1.3. Small Hospitals 5.2.2. Long-term Care Facilities 5.2.2.1. Nursing Homes 5.2.2.2. Skilled Nursing Facilities 5.2.2.3. Assisted- Living Facilities 5.2.3. Other End Users 5.3. Europe Infection Surveillance Solutions Market Outlook, by Country, Value (US$ Mn), 2020-2033 5.3.1. Germany Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.2. Germany Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.3.3. Italy Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.4. Italy Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.3.5. France Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.6. France Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.3.7. U.K. Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.8. U.K. Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.3.9. Spain Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.10. Spain Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.3.11. Russia Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.12. Russia Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.3.13. Rest of Europe Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 5.3.14. Rest of Europe Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 5.4. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Infection Surveillance Solutions Market Outlook, 2020-2033 6.1. Asia Pacific Infection Surveillance Solutions Market Outlook, by Product & Services, Value (US$ Mn), 2020-2033 6.1.1. Software 6.1.1.1. On-premise Software 6.1.1.2. Web-based Software 6.1.2. Up to 50 hp 6.1.2.1. Product Support & Maintenance Services 6.1.2.2. Implementation Services 6.1.2.3. Training & Consulting services 6.2. Asia Pacific Infection Surveillance Solutions Market Outlook, by End User, Value (US$ Mn), 2020-2033 6.2.1. Hospitals 6.2.1.1. Large Hospitals 6.2.1.2. Medium Sized Hospitals 6.2.1.3. Small Hospitals 6.2.2. Long-term Care Facilities 6.2.2.1. Nursing Homes 6.2.2.2. Skilled Nursing Facilities 6.2.2.3. Assisted- Living Facilities 6.2.3. Other End Users 6.3. Asia Pacific Infection Surveillance Solutions Market Outlook, by Country, Value (US$ Mn), 2020-2033 6.3.1. China Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 6.3.2. China Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 6.3.3. Japan Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 6.3.4. Japan Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 6.3.5. South Korea Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 6.3.6. South Korea Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 6.3.7. India Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 6.3.8. India Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 6.3.9. Southeast Asia Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 6.3.10. Southeast Asia Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 6.3.11. Rest of SAO Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 6.3.12. Rest of SAO Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 6.4. BPS Analysis/Market Attractiveness Analysis 7. Latin America Infection Surveillance Solutions Market Outlook, 2020-2033 7.1. Latin America Infection Surveillance Solutions Market Outlook, by Product & Services, Value (US$ Mn), 2020-2033 7.1.1. Software 7.1.1.1. On-premise Software 7.1.1.2. Web-based Software 7.1.2. Up to 50 hp 7.1.2.1. Product Support & Maintenance Services 7.1.2.2. Implementation Services 7.1.2.3. Training & Consulting services 7.2. Latin America Infection Surveillance Solutions Market Outlook, by End User, Value (US$ Mn), 2020-2033 7.2.1. Hospitals 7.2.1.1. Large Hospitals 7.2.1.2. Medium Sized Hospitals 7.2.1.3. Small Hospitals 7.2.2. Long-term Care Facilities 7.2.2.1. Nursing Homes 7.2.2.2. Skilled Nursing Facilities 7.2.2.3. Assisted- Living Facilities 7.2.3. Other End Users 7.3. Latin America Infection Surveillance Solutions Market Outlook, by Country, Value (US$ Mn), 2020-2033 7.3.1. Brazil Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 7.3.2. Brazil Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 7.3.3. Mexico Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 7.3.4. Mexico Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 7.3.5. Argentina Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 7.3.6. Argentina Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 7.3.7. Rest of LATAM Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 7.3.8. Rest of LATAM Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 7.4. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Infection Surveillance Solutions Market Outlook, 2020-2033 8.1. Middle East & Africa Infection Surveillance Solutions Market Outlook, by Product & Services, Value (US$ Mn), 2020-2033 8.1.1. Software 8.1.1.1. On-premise Software 8.1.1.2. Web-based Software 8.1.2. Up to 50 hp 8.1.2.1. Product Support & Maintenance Services 8.1.2.2. Implementation Services 8.1.2.3. Training & Consulting services 8.2. Middle East & Africa Infection Surveillance Solutions Market Outlook, by End User, Value (US$ Mn), 2020-2033 8.2.1. Hospitals 8.2.1.1. Large Hospitals 8.2.1.2. Medium Sized Hospitals 8.2.1.3. Small Hospitals 8.2.2. Long-term Care Facilities 8.2.2.1. Nursing Homes 8.2.2.2. Skilled Nursing Facilities 8.2.2.3. Assisted- Living Facilities 8.2.3. Other End Users 8.3. Middle East & Africa Infection Surveillance Solutions Market Outlook, by Country, Value (US$ Mn), 2020-2033 8.3.1. GCC Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 8.3.2. GCC Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 8.3.3. South Africa Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 8.3.4. South Africa Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 8.3.5. Egypt Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 8.3.6. Egypt Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 8.3.7. Nigeria Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 8.3.8. Nigeria Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 8.3.9. Rest of Middle East Infection Surveillance Solutions Market Outlook, by Product & Services, 2020-2033 8.3.10. Rest of Middle East Infection Surveillance Solutions Market Outlook, by End User, 2020-2033 8.4. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Becton, Dickinson and Company 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Premier, Inc. 9.4.3. Wolters Kluwer N.V. 9.4.4. Cerner Corporation 9.4.5. Baxter International Inc. 9.4.6. RLDatix 9.4.7. VigiLanz Corporation 9.4.8. GOJO Industries, Inc. 9.4.9. bioMérieux SA 9.4.10. Clinisys 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD（infection）の最新刊レポートよくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
